| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996387460103316 |
|
|
Titolo |
By the King, a proclamation for enforcing the due execution of the act of Parliament entituled An Act for Settling the Profits of the Post-Office on His Royal Highness the Duke of York, and his heirs males and for prevention of treasonable correspondencies [[electronic resource] ] : and other inconveniences arising by the infringement of the said act |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, : Printed by the assigns of John Bill deceas'd and by Henry Hills and Thomas Newcomb ..., 1683 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Altri autori (Persone) |
|
Charles, King of England, <1630-1685.> |
|
|
|
|
|
|
Soggetti |
|
Great Britain History Charles II, 1660-1685 |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
"Given at our court at Windsor the 25th of August, 1683, in the five and thirtieth year of our reign." |
Reproduction of original in the Huntington Library. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910965645303321 |
|
|
Titolo |
Systemic treatment of prostate cancer / / edited by Alan Horwich |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford ; ; New York, : Oxford University Press, 2010 |
|
|
|
|
|
|
|
ISBN |
|
0-19-174025-X |
0-19-960737-0 |
1-283-34833-0 |
9786613348333 |
0-19-157581-X |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (102 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Prostate - Cancer - Diagnosis |
Prostate - Cancer - Treatment |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Preface; Symbols and abbreviations; Contributors; 1 Biological principles of hormone therapy; 2 PSA as a marker of progression and response in advanced prostate cancer; 3 Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer; 4 Systemic treatment of recurrence after local therapies; 5 First-line hormone therapy for metastatic prostate cancer; 6 Second- and third-line hormone therapies; 7 Chemotherapy for metastatic prostate cancer; 8 The role of bisphosphonates in the systemic treatment of prostate cancer; 9 Systemic isotope therapy of bone metastasis |
10 Biological targets and new drug development for prostate cancerIndex; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Z |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti- |
|
|
|
|
|
|
|
|
|
|
androgens, oestrogens and corticosteroids can also cause r |
|
|
|
|
|
| |